United Therapeutics | UTHR - Ingresos Por Ventas

Precio De Mercado
567.16
Cambio Diario
-5.69 -0.99%
Mensual
4.72%
Anual
94.65%
Q2 Expectativa
555.02




Ventas Cambio Fecha
Amarin USD 49.22M 451K 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Baxter International USD 2.97B 130M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.28B 250M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Halozyme Therapeutics USD 451.76M 97.76M 2025-12
Insmed USD 263.8M 121.8M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
J&J USD 24.1B 500M 2026-03
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Moderna USD 678M 342M 2025-12
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12